BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 26935427)

  • 1. Controlled Release of Chitosan and Sericin from the Microspheres-Embedded Wound Dressing for the Prolonged Anti-microbial and Wound Healing Efficacy.
    Aramwit P; Yamdech R; Ampawong S
    AAPS J; 2016 May; 18(3):647-58. PubMed ID: 26935427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of non-toxic ionic-crosslinked chitosan-based microspheres as carriers for the controlled release of silk sericin.
    Aramwit P; Ekasit S; Yamdech R
    Biomed Microdevices; 2015 Oct; 17(5):84. PubMed ID: 26233725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of ethyl alcohol-precipitated silk sericin/polyvinyl alcohol scaffolds for accelerated healing of full-thickness wounds.
    Siritienthong T; Ratanavaraporn J; Aramwit P
    Int J Pharm; 2012 Dec; 439(1-2):175-86. PubMed ID: 23022662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of Physical and Wound Adhesion Properties of Silk Sericin and Polyvinyl Alcohol Dressing Using Glycerin.
    Aramwit P; Ratanavaraporn J; Siritientong T
    Adv Skin Wound Care; 2015 Aug; 28(8):358-67. PubMed ID: 26181860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and performance of sericin/poly(vinyl alcohol) hydrogel as a drug delivery carrier for potential wound dressing application.
    Tao G; Wang Y; Cai R; Chang H; Song K; Zuo H; Zhao P; Xia Q; He H
    Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():341-351. PubMed ID: 31029327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of long-term stability and antimicrobial activity of chlorhexidine, polyhexamethylene biguanide, and silver nanoparticle incorporated in sericin-based wound dressing.
    Ampawong S; Aramwit P
    J Biomater Sci Polym Ed; 2017 Sep; 28(13):1286-1302. PubMed ID: 28420291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A green salt-leaching technique to produce sericin/PVA/glycerin scaffolds with distinguished characteristics for wound-dressing applications.
    Aramwit P; Ratanavaraporn J; Ekgasit S; Tongsakul D; Bang N
    J Biomed Mater Res B Appl Biomater; 2015 May; 103(4):915-24. PubMed ID: 25175958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the PVA/CS nanofibers containing silk protein sericin as a wound dressing: In vitro and in vivo assessment.
    Bakhsheshi-Rad HR; Ismail AF; Aziz M; Akbari M; Hadisi Z; Omidi M; Chen X
    Int J Biol Macromol; 2020 Apr; 149():513-521. PubMed ID: 31954780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated healing of full-thickness wounds by genipin-crosslinked silk sericin/PVA scaffolds.
    Aramwit P; Siritienthong T; Srichana T; Ratanavaraporn J
    Cells Tissues Organs; 2013; 197(3):224-38. PubMed ID: 23307034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of bacterial nanocellulose wound dressing incorporating sericin and polyhexamethylene biguanide: in vitro, in vivo and clinical studies.
    Napavichayanun S; Yamdech R; Aramwit P
    Arch Dermatol Res; 2016 Mar; 308(2):123-32. PubMed ID: 26796543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wound healing applications of sericin/chitosan-capped silver nanoparticles incorporated hydrogel.
    Verma J; Kanoujia J; Parashar P; Tripathi CB; Saraf SA
    Drug Deliv Transl Res; 2017 Feb; 7(1):77-88. PubMed ID: 27565984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic responses of CD206+, CD83+, FOXP3+, and CTLA-4 to sericin/polyvinyl alcohol/glycerin scaffolds relevant to IL-33 and HSP60 activity.
    Ampawong S; Aramwit P
    Histol Histopathol; 2016 Sep; 31(9):1011-27. PubMed ID: 26864661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial chitosan/silk sericin 3D porous scaffolds as a wound dressing material.
    Karahaliloglu Z; Kilicay E; Denkbas EB
    Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-14. PubMed ID: 27396677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalently antibacterial alginate-chitosan hydrogel dressing integrated gelatin microspheres containing tetracycline hydrochloride for wound healing.
    Chen H; Xing X; Tan H; Jia Y; Zhou T; Chen Y; Ling Z; Hu X
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):287-295. PubMed ID: 27770893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of silk sericin based nanofibrous mats for wound dressing applications.
    Gilotra S; Chouhan D; Bhardwaj N; Nandi SK; Mandal BB
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():420-432. PubMed ID: 29853108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An innovative bi-layered wound dressing made of silk and gelatin for accelerated wound healing.
    Kanokpanont S; Damrongsakkul S; Ratanavaraporn J; Aramwit P
    Int J Pharm; 2012 Oct; 436(1-2):141-53. PubMed ID: 22771972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The wound healing and antibacterial potential of triple-component nanocomposite (chitosan-silver-sericin) films loaded with moxifloxacin.
    Shah A; Ali Buabeid M; Arafa EA; Hussain I; Li L; Murtaza G
    Int J Pharm; 2019 Jun; 564():22-38. PubMed ID: 31002933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical potential of a silk sericin-releasing bioactive wound dressing for the treatment of split-thickness skin graft donor sites.
    Siritientong T; Angspatt A; Ratanavaraporn J; Aramwit P
    Pharm Res; 2014 Jan; 31(1):104-16. PubMed ID: 23900888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated full-thickness wound healing via sustained bFGF delivery based on a PVA/chitosan/gelatin hydrogel incorporating PCL microspheres.
    Shamloo A; Sarmadi M; Aghababaie Z; Vossoughi M
    Int J Pharm; 2018 Feb; 537(1-2):278-289. PubMed ID: 29288809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin-loaded chitosan/Pluronic® F127 microspheres as in situ forming hydrogel: An innovative antimicrobial wound dressing.
    Romić MD; Klarić MŠ; Lovrić J; Pepić I; Cetina-Čižmek B; Filipović-Grčić J; Hafner A
    Eur J Pharm Biopharm; 2016 Oct; 107():67-79. PubMed ID: 27329001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.